CellWell record HH-107691
Particle Number vs. Cholesterol Mass: The Emerging Role of ApoB in Refining Cardiovascular Risk Stratification
Sofia-Panagiota Giannakopoulou
International Journal of Clinical and Translational Medicine ยท 2026
In plain language
ApoB superior marker for risk stratification than LDL-C; measures particle number not mass; Mendelian randomization shows causal ASCVD association; universal assay harmonization and insurance reimbursement barriers limit adoption.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-107691
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.